ArticleCancers2022

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.

Laura V Bownes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.